Mandy Deimel

Managing Director Pharma, Diagnostic And GMP at Eurofins Genomics

Mandy Deimel has a diverse work experience spanning across various industries. Mandy currently holds the position of Managing Director at Eurofins Genomics, overseeing the Pharma, Diagnostic, and GMP sectors. Prior to this, they were the Managing Director of the DNA Synthesis Business at the same company.

Before joining Eurofins Genomics, Mandy worked at Invacare Corporation as the VP of Corporate Quality & Regulatory Affairs, responsible for the EMEA, US, and APAC regions. Mandy also had a role at Invacare Europe as the VP of Quality & Regulatory Affairs for the EMEA region.

Mandy's experience in the scientific field includes working at Thermo Fisher Scientific as the Director of QARA and Customer Excellence, as well as the Director of Quality and Operational Excellence. Mandy also had a brief role at BMW Group as the Head of PMO.

Earlier in their career, Mandy held the position of Head of Quality Germany at Assystem and worked as a Senior Project Manager at QUISS GmbH. Mandy started their career as an Application Engineer at 3D image processing GmbH.

Overall, Mandy Deimel's work experience encompasses leadership and management roles in quality, regulatory affairs, and project management within various industries.

Mandy Deimel completed their education with a Master of Business Administration - Executive MBA from the TUM School of Management between 2017 and 2020. Prior to that, they earned a Dipl.-Ing. degree in Ingenieurvermessung & Geoinformatik from FHT Stuttgart in the years 1997 to 2003. In 2002, Mandy Deimel also obtained a Diplom-Ingenieurin degree from The University of Queensland. Additionally, they obtained a Lean Six Sigma Black Belt certification from SIX SIGMA Dienstleistungen GmbH in December 2018.

Links

Previous companies

Invacare logo
Assystem logo
Thermo Fisher Scientific logo

Timeline

  • Managing Director Pharma, Diagnostic And GMP

    September, 2022 - present

  • Managing Director DNA Synthesis Business

    September, 2021

View in org chart